COM:ATARABIO
Atara Biotherapeutics Inc
- Stock
Last Close
10.61
22/11 21:00
Market Cap
66.06M
Beta: -
Volume Today
65.66K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -8.77M - | -28.01M 219.23% | -57.22M 104.32% | -79.05M 38.15% | -119.49M 51.16% | -230.70M 93.07% | -290.98M 26.13% | -306.62M 5.38% | -340.14M 10.93% | -228.30M 32.88% | -276.13M 20.95% | |
depreciation and amortization | 4K - | 6K 50% | 48K 700% | 383K 697.92% | 956K 149.61% | 3.73M 290.38% | 7.07M 89.44% | 8.33M 17.85% | 9.35M 12.16% | 5.65M 39.51% | 5.62M 0.57% | |
deferred income tax | 526K - | -1.89M - | -303K 83.93% | 958K 416.17% | 1.79M 86.85% | |||||||
stock based compensation | 1.71M - | 10.10M 489.67% | 10.25M 1.49% | 16.78M 63.73% | 23.10M 37.63% | 33.82M 46.39% | 51.70M 52.87% | 51.35M 0.67% | 53.87M 4.90% | 53.84M 0.05% | 45.39M 15.70% | |
change in working capital | 1.09M - | -3K 100.27% | 6.19M 206,300% | -725K 111.72% | 7.20M 1,093.24% | 15.00M 108.35% | -4.15M 127.65% | 63.69M 1,635.32% | 52.58M 17.43% | -61.47M 216.89% | -5.14M 91.64% | |
accounts receivables | -1.25M - | 264K 121.12% | -39.23M 14,961.74% | 6.11M 115.58% | ||||||||
inventory | -1.25M - | 3.34M 367.01% | -1.59M 147.44% | -8.12M 411.98% | ||||||||
accounts payables | 485K - | -164K 133.81% | 1.00M 712.80% | 981K 2.39% | 2.16M 120.49% | -1.96M 190.52% | 4.21M 315.17% | -815K 119.34% | 9.07M 1,212.52% | -9.21M 201.59% | -3.13M 66.02% | |
other working capital | 609K - | 161K 73.56% | 5.18M 3,118.01% | -1.71M 132.93% | 5.04M 395.31% | 16.96M 236.66% | -8.36M 149.30% | 67.00M 901.36% | 39.91M 40.43% | -11.44M 128.65% | 5.14M 144.92% | |
other non cash items | -4K - | 748K 18,800% | 3.58M 378.61% | 2.58M 27.88% | 732K 71.65% | 260K 64.48% | 1.03M 298.08% | 1.53M 48.31% | 2.04M 32.57% | -40.15M 2,073.02% | 32.14M 180.05% | |
net cash provided by operating activities | -5.97M - | -16.63M 178.71% | -37.16M 123.45% | -60.02M 61.55% | -87.50M 45.78% | -179.77M 105.45% | -235.63M 31.07% | -180.76M 23.29% | -220.52M 22.00% | -270.43M 22.63% | -192.98M 28.64% | |
investments in property plant and equipment | -3K - | -46K 1,433.33% | -290K 530.43% | -3.02M 941.38% | -20.23M 569.93% | -35.92M 77.57% | -5.73M 84.04% | -4.51M 21.28% | -10.58M 134.43% | -4.19M 60.37% | -1.22M 70.83% | |
acquisitions net | -83.74M - | 161K - | 116.22M 72,083.23% | -32.84M 128.26% | 94.77M 388.58% | |||||||
purchases of investments | -95.53M - | -379.78M 297.57% | -304.93M 19.71% | -176.46M 42.13% | -466.49M 164.36% | -270.23M 42.07% | -425.87M 57.59% | -301.13M 29.29% | -180.59M 40.03% | -83.65M 53.68% | ||
sales maturities of investments | 12.21M - | 160.13M 1,211.71% | 391.69M 144.60% | 296.60M 24.28% | 306.13M 3.21% | 336.26M 9.84% | 309.65M 7.91% | 333.97M 7.85% | 292.97M 12.27% | 208.71M 28.76% | ||
other investing activites | -194K - | 83.74M 43,265.46% | -1.20M 101.43% | -116.22M - | 32.84M 128.26% | 25K - | ||||||
net cash used for investing activites | -3K - | -83.36M 2,778,666.67% | -220.13M 164.06% | 83.74M 138.04% | 98.71M 17.87% | -196.29M 298.86% | 60.46M 130.80% | -120.73M 299.69% | 22.26M 118.44% | 202.96M 811.83% | 123.87M 38.97% | |
debt repayment | -528K - | -486K 7.95% | -389K 19.96% | -254K 34.70% | -518K 103.94% | -947K 82.82% | ||||||
common stock issued | 56.45M - | 263.43M 366.63% | 19.16M - | 340.88M 1,679.47% | 188.62M 44.67% | 422.97M 124.25% | 98.70M 76.67% | 52.50M 46.81% | 2.14M 95.93% | |||
common stock repurchased | -6.70M - | -1.52M 77.28% | -1.24M 18.21% | -623K 49.92% | ||||||||
dividends paid | -6.70M - | -1.52M 77.28% | -1.24M 18.21% | -623K 49.92% | ||||||||
other financing activites | 53.38M - | 13.82M 74.11% | -4.21M 130.45% | 506K 112.02% | 892K 76.28% | 17.19M 1,826.91% | 14.04M 18.29% | 8.04M 42.78% | 7.99M 0.58% | 2.35M 70.56% | 821K 65.09% | |
net cash used provided by financing activities | 53.38M - | 70.27M 31.65% | 259.23M 268.88% | 506K 99.80% | 20.05M 3,862.06% | 357.54M 1,683.40% | 188.79M 47.20% | 427.57M 126.49% | 103.94M 75.69% | 53.08M 48.93% | 2.01M 96.21% | |
effect of forex changes on cash | -94K - | |||||||||||
net change in cash | 47.41M - | -29.72M 162.69% | 1.85M 106.22% | 24.22M 1,210.01% | 31.25M 29.04% | -18.52M 159.27% | 13.62M 173.52% | 126.09M 825.82% | -94.32M 174.81% | -14.39M 84.74% | -67.10M 366.30% | |
cash at beginning of period | 4.21M - | 51.62M 1,126.88% | 21.90M 57.58% | 23.75M 8.44% | 47.97M 102.00% | 80.62M 68.06% | 62.09M 22.98% | 75.71M 21.93% | 201.80M 166.54% | 107.48M 46.74% | 93.09M 13.39% | |
cash at end of period | 51.62M - | 21.90M 57.58% | 23.75M 8.44% | 47.97M 102.00% | 79.22M 65.16% | 62.09M 21.62% | 75.71M 21.93% | 201.80M 166.54% | 107.48M 46.74% | 93.09M 13.39% | 25.99M 72.08% | |
operating cash flow | -5.97M - | -16.63M 178.71% | -37.16M 123.45% | -60.02M 61.55% | -87.50M 45.78% | -179.77M 105.45% | -235.63M 31.07% | -180.76M 23.29% | -220.52M 22.00% | -270.43M 22.63% | -192.98M 28.64% | |
capital expenditure | -3K - | -46K 1,433.33% | -290K 530.43% | -3.02M 941.38% | -20.23M 569.93% | -35.92M 77.57% | -5.73M 84.04% | -4.51M 21.28% | -10.58M 134.43% | -4.19M 60.37% | -1.22M 70.83% | |
free cash flow | -5.97M - | -16.67M 179.34% | -37.45M 124.58% | -63.05M 68.36% | -107.73M 70.88% | -215.70M 100.21% | -241.36M 11.90% | -185.27M 23.24% | -231.10M 24.74% | -274.62M 18.83% | -194.20M 29.28% |
All numbers in (except ratios and percentages)